We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.37B
AUM Growth
+$566M
Cap. Flow
+$197M
Cap. Flow %
4.52%
Top 10 Hldgs %
75.62%
Holding
311
New
26
Increased
196
Reduced
22
Closed
17

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.9M
2
MSGS icon
Madison Square Garden
MSGS
+$23.3M
3
MSFT icon
Microsoft
MSFT
+$14.8M
4
AMZN icon
Amazon
AMZN
+$12.7M
5
NVDA icon
NVIDIA
NVDA
+$12.5M

Sector Composition

Rank Sector Weight
1 Healthcare 56.07%
2 Technology 8.45%
3 Energy 6.73%
4 Consumer Discretionary 4.64%
5 Utilities 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MZTI
301
The Marzetti Company
MZTI
$2.94B
-3
Closed -$518
LRCX icon
302
Lam Research
LRCX
$382B
-258
Closed -$19K
OMCL icon
303
Omnicell
OMCL
$1.86B
$0 ﹤0.01%
1
REZI icon
304
Resideo Technologies
REZI
$5.23B
$0 ﹤0.01%
16
RMD icon
305
ResMed
RMD
$28.3B
-1
Closed
SAH icon
306
Sonic Automotive
SAH
$3.15B
-2,651
Closed -$151K
SPY icon
307
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
-6,000
Closed -$6.18M
TPYP icon
308
Tortoise North American Pipeline ETF
TPYP
$900M
-68,221
Closed -$2.48M
TXN icon
309
Texas Instruments
TXN
$255B
-1,397
Closed -$251K
UMC icon
310
United Microelectronic
UMC
$48.9B
-1
Closed
VTRS icon
311
Viatris
VTRS
$20.1B
$0 ﹤0.01%
29

Similar funds

Bollard Group's Q2 2025 Portfolio in Review

As of Q2 2025, Bollard Group held 311 positions worth $4.37B, up 15% from $3.81B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bollard Group deployed $197M of net new capital in Q2 2025, opening 26 new positions and adding to 196 existing holdings. Its largest new stake was Madison Square Garden: 121,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $41.6M trimmed.

  • Bollard Group's largest Q2 2025 buy was Madison Square Garden: 121,000 shares worth $25.3M.
  • Bollard Group added most to Thermo Fisher Scientific in Q2 2025, an estimated $25.9M increase.
  • Bollard Group's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $41.6M.
  • Bollard Group fully exited HF Sinclair in Q2 2025, selling an estimated $6.4M.
  • Bollard Group's ten largest holdings make up 76% of its $4.37B portfolio in Q2 2025.
  • Bollard Group opened 26 new positions and closed 17 in Q2 2025.
  • Bollard Group's portfolio value rose 15% quarter-over-quarter to $4.37B.

Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.